13.45 USD
+0.18 (+1.36%)
13.23 USD
-0.22 (-1.64%)
Overall CLSK gets a fundamental rating of 4 out of 10. We evaluated CLSK against 278 industry peers in the Software industry. While CLSK seems to be doing ok healthwise, there are quite some concerns on its profitability. CLSK is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
- In the past year CLSK was profitable.
- CLSK had a negative operating cash flow in the past year.
- In the past 5 years CLSK reported 4 times negative net income.
- CLSK had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 11.10%, CLSK belongs to the top of the industry, outperforming 87.05% of the companies in the same industry.
- CLSK has a better Return On Equity (16.24%) than 83.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.1% | ||
| ROE | 16.24% | ||
| ROIC | N/A |
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CLSK has a better Profit Margin (46.11%) than 93.17% of its industry peers.
- With a Gross Margin value of 55.23%, CLSK is not doing good in the industry: 65.47% of the companies in the same industry are doing better.
- CLSK's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 46.11% | ||
| GM | 55.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
2. Health
2.1 Basic Checks
- CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CLSK has more shares outstanding
- Compared to 5 years ago, CLSK has more shares outstanding
- CLSK has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.50 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
- CLSK's Altman-Z score of 2.50 is in line compared to the rest of the industry. CLSK outperforms 56.12% of its industry peers.
- CLSK has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
- CLSK has a Debt to Equity ratio of 0.30. This is in the lower half of the industry: CLSK underperforms 60.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.5 |
ROIC/WACCN/A
WACC10.74%
2.3 Liquidity
- CLSK has a Current Ratio of 4.18. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 4.18, CLSK belongs to the best of the industry, outperforming 82.73% of the companies in the same industry.
- CLSK has a Quick Ratio of 4.18. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
- CLSK's Quick ratio of 4.18 is amongst the best of the industry. CLSK outperforms 82.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.18 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
- CLSK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1242.86%, which is quite impressive.
- Looking at the last year, CLSK shows a very strong growth in Revenue. The Revenue has grown by 102.21%.
- The Revenue has been growing by 138.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1242.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.3%
Revenue 1Y (TTM)102.21%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%150.52%
3.2 Future
- The Earnings Per Share is expected to decrease by -68.41% on average over the next years. This is quite bad
- Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 28.19% on average per year.
EPS Next Y-115.57%
EPS Next 2Y-66.02%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y14.03%
Revenue Next 3Y28.19%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.31, CLSK is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of CLSK indicates a rather cheap valuation: CLSK is cheaper than 82.01% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.60, CLSK is valued a bit cheaper.
- The Forward Price/Earnings Ratio is negative for CLSK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.31 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- CLSK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLSK is cheaper than 89.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.46 |
4.3 Compensation for Growth
- A cheap valuation may be justified as CLSK's earnings are expected to decrease with -68.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.02%
EPS Next 3Y-68.41%
5. Dividend
5.1 Amount
- No dividends for CLSK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CLEANSPARK INC / CLSK FAQ
What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?
ChartMill assigns a fundamental rating of 4 / 10 to CLSK.
What is the valuation status of CLEANSPARK INC (CLSK) stock?
ChartMill assigns a valuation rating of 2 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.
Can you provide the profitability details for CLEANSPARK INC?
CLEANSPARK INC (CLSK) has a profitability rating of 3 / 10.
What is the earnings growth outlook for CLEANSPARK INC?
The Earnings per Share (EPS) of CLEANSPARK INC (CLSK) is expected to decline by -115.57% in the next year.
Is the dividend of CLEANSPARK INC sustainable?
The dividend rating of CLEANSPARK INC (CLSK) is 0 / 10 and the dividend payout ratio is 3.04%.